The AI in Healthcare Market is rapidly expanding the frontiers of precision medicine through deep learning technologies, enabling highly customized treatment strategies based on genetic, environmental, and lifestyle data. This evolution marks a shift from reactive to predictive and preventative healthcare, where AI plays a pivotal role in analyzing complex biological patterns and guiding more...
The animal genetics market is evolving rapidly, with a growing emphasis on precision medicine in veterinary genetics. Just as precision medicine has transformed human healthcare by providing more personalized and effective treatments, its integration into veterinary care and animal genetics is revolutionizing how we manage the health, breeding, and welfare of animals. Veterinary precision...
🧬 1. Monoclonal Antibodies: Foundation of Modern Oncology
Monoclonal antibodies (mAbs) continue to anchor the Anticancer Drugs Market. In 2025, global sales for cancer-specific mAbs are projected to be USD 92–105 billion, soaring toward nearly USD 577 billion by 2034, at a remarkable CAGR of ~18–19% . These biologics—including humanized (Trastuzumab, Bevacizumab)...
According to recent findings, the Global Artificial Intelligence (AI) in Precision Medicine Market size was valued at USD 1.7 billion in 2023 and is projected to reach USD 14.5 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 27% during the forecast period, i.e., 2024-30.
At MarkNtel Advisors, we continuously monitor and...
The Biobetters Market Emerging Trends are being significantly shaped by advanced technologies such as artificial intelligence (AI), genomics, and precision medicine. These innovations are transforming the development of biologic therapies, enabling companies to design next-generation biobetters with enhanced efficacy, safety, and patient specificity. As biobetters evolve beyond conventional...
The live cell monitoring market has undergone significant innovations in recent years, transforming how researchers and clinicians study cellular behavior in real-time. Driven by rapid advancements in imaging technologies, artificial intelligence (AI), and bioengineering, these innovations are enabling unprecedented insights into dynamic biological processes. As biotechnology and pharmaceutical...
[New York, 17th June 2025] – The global melanoma treatment market is poised for transformative growth, projected to expand from USD 5.2 billion in 2023 to USD 12.4 billion by 2035, at a CAGR of 10.8%, according to Clearview Market Insights. This growth is driven by revolutionary advancements in immune checkpoint inhibitors, targeted therapies, and AI-driven...
Boston, 04th June 2025 – The global market for Next-Generation Sequencing reagents is projected to leap from USD 1.85 billion in 2024 to USD 3.95 billion by 2031, registering a robust CAGR of 11.2%, according to a new report by Clearview Market Insights (CVMI).
“As sequencing becomes a frontline diagnostic tool, laboratories are demanding reagents that are faster, more...
Compounding Pharmacies Market Overview
Maximize Market Research is a Business Consultancy Firm that has published a detailed analysis of the “Compounding Pharmacies Market”. The report includes key business insights, demand analysis, pricing analysis, and competitive landscape. The report provides the current state of the Compounding Pharmacies market by...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian
Greek